IRCM-Caps: An X-ray image detection method for COVID-19

IRCM-Caps:一种用于检测新冠病毒的X射线图像方法

阅读:1

Abstract

OBJECTIVE: COVID-19 is ravaging the world, but traditional reverse transcription-polymerase reaction (RT-PCR) tests are time-consuming and have a high false-negative rate and lack of medical equipment. Therefore, lung imaging screening methods are proposed to diagnose COVID-19 due to its fast test speed. Currently, the commonly used convolutional neural network (CNN) model requires a large number of datasets, and the accuracy of the basic capsule network for multiple classification is limital. For this reason, this paper proposes a novel model based on CNN and CapsNet. METHODS: The proposed model integrates CNN and CapsNet. And attention mechanism module and multi-branch lightweight module are applied to enhance performance. Use the contrast adaptive histogram equalization (CLAHE) algorithm to preprocess the image to enhance image contrast. The preprocessed images are input into the network for training, and ReLU was used as the activation function to adjust the parameters to achieve the optimal. RESULT: The test dataset includes 1200 X-ray images (400 COVID-19, 400 viral pneumonia, and 400 normal), and we replace CNN of VGG16, InceptionV3, Xception, Inception-Resnet-v2, ResNet50, DenseNet121, and MoblieNetV2 and integrate with CapsNet. Compared with CapsNet, this network improves 6.96%, 7.83%, 9.37%, 10.47%, and 10.38% in accuracy, area under the curve (AUC), recall, and F1 scores, respectively. In the binary classification experiment, compared with CapsNet, the accuracy, AUC, accuracy, recall rate, and F1 score were increased by 5.33%, 5.34%, 2.88%, 8.00%, and 5.56%, respectively. CONCLUSION: The proposed embedded the advantages of traditional convolutional neural network and capsule network and has a good classification effect on small COVID-19 X-ray image dataset.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。